Distributions of intravenous injected iodine nanoparticles in orthotopic u87 human glioma xenografts over time and tumor therapy

Nanomedicine (Lond). 2020 Oct;15(24):2369-2383. doi: 10.2217/nnm-2020-0178. Epub 2020 Sep 25.

Abstract

Aim: To analyze the localization, distribution and effect of iodine nanoparticles (INPs) on radiation therapy (RT) in advanced intracerebral gliomas over time after intravenous injection. Materials & methods: Luciferase/td-tomato expressing U87 human glioma cells were implanted into mice which were injected intravenously with INPs. Mice with gliomas were followed for tumor progression and survival. Immune-stained mouse brain sections were examined and quantified by confocal fluorescence microscopy. Results: INPs injected intravenously 3 days prior to RT, compared with 1 day, showed greater association with CD31-staining structures, accumulated inside tumor cells more, covered more of the tumor cell surface and trended toward increased median survival. Conclusion: INP persistence and redistribution in tumors over time may enable greater RT enhancement and clinically relevant hypo-fractionated-RT and may enhance INP efficacy.

Keywords: distribution; fractionated radiation therapy; glioma radiotherapy; iodine nanoparticles; microlocalization; radiation therapy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Neoplasms* / drug therapy
  • Cell Line, Tumor
  • Glioma* / drug therapy
  • Heterografts
  • Humans
  • Injections, Intravenous
  • Iodine* / therapeutic use
  • Mice
  • Mice, Nude
  • Nanoparticles*

Substances

  • Iodine